Menu
Currency
GWAS Study

Genetic variants of CYP4F12 gene are associated with glioma susceptibility.

Li N, Shi H, Hou P et al.

34319593 PubMed ID
GWAS Study Type
970 Participants
27 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LN
Li N
SH
Shi H
HP
Hou P
GL
Gao L
SY
Shi Y
MW
Mi W
ZG
Zhang G
WN
Wang N
DW
Dai W
WL
Wei L
JT
Jin T
SY
Shi Y
GS
Guo S
Chapter II

Abstract

Summary of the research findings

Glioma is a common and fatal primary malignant tumor of the central nervous system, and its prognosis is poor. To determine the susceptibility markers of gliomas in Chinese population we conducted a genome-wide association study (GWAS) of glioma in the Han Chinese population, with a total of 485 glioma cases and 485 controls. Genotyping was conducted using the Applied Biosystems Axiom Precision Medicine Diversity Array. Besides, we carried out imputation using IMPUTE 2.0 software, and the 1000 Genomes Phase 3 was used as the reference panel. The logistic regression model was used to analyze the association of each SNP with glioma risk, assuming an additive genetic model, which was implemented in PLINK version 1.9. Odds ratio (OR) and 95% confidence interval (CI) were estimated from logistic regression analysis with adjustment for age and gender. The results revealed that the SNP (rs688755) in the exon region of CYP4F12 at 19p13.12 reached genome-wide significance associated with gliomas (P = 2.35 × 10-8 , OR = 3.55, 95% CI = 2.20-5.74). Our findings provide deeper insight into the genetic contribution to glioma in different populations.

485 Han Chinese ancestry cases, 485 Han Chinese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

970
Total Participants
GWAS
Study Type
No
Replicated
East Asian
Ancestry
China
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.